JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2002; 39:301-307
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maron, B. J.
Right arrow Articles by Spirito, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maron, B. J.
Right arrow Articles by Spirito, P.

CLINICAL STUDY: HYPERTROPHIC CARDIOMYOPATHY

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

Barry J. Maron, MD, FACC*,*, Iacopo Olivotto, MD{dagger}, Pietro Bellone, MD{ddagger}, Maria Rosa Conte, MD§, Franco Cecchi, MD{dagger}, Björn P. Flygenring, MD, FACC*, Susan A. Casey, RN*, Thomas E. Gohman, BA*, Sergio Bongioanni, MD§ and Paolo Spirito, MD, FACC||

* Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
{dagger} Ospedale di Careggi, Florence, Italy
{ddagger} Ospedale Santa Corona, Pietra Ligure, Italy
§ Ospedale di Rivoli, Turin, Italy
|| Ente Ospedaliero Ospedali Galliera, Genoa, Italy

Manuscript received November 21, 2000; revised manuscript received September 25, 2001, accepted October 19, 2001.

* Reprint requests and correspondence: Dr. Barry J. Maron, Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 60, Minneapolis, Minnesota 55407, USA.
hcm.maron{at}mhif.org

OBJECTIVES: We sought to assess the occurrence and clinical significance of stroke and peripheral arterial embolizations at non-central nervous system sites in a large, community-based cohort with hypertrophic cardiomyopathy (HCM).

BACKGROUND: Such vascular events are insufficiently appreciated complications of HCM for which there is limited information on occurrence, clinical profile and determinants.

METHODS: We assessed the clinical features of patients with stroke and other peripheral vascular events in a consecutive group of patients with HCM from four regional cohorts not subject to significant tertiary referral bias.

RESULTS: Of the 900 patients, 51 (6%) patients experienced stroke or other vascular events over 7 ± 7 years, including 44 patients with stroke; 21 (41%) of these 51 patients died or were permanently disabled. The overall incidence was 0.8%/year and 1.9% for patients >60 years old. Age at first event ranged from 29 to 86 years (mean 61 ± 14 years). Most (n = 37; 72%) events occurred in those >50 years, although 14 (28%) younger patients (≤50 years) also had events. Multivariate analysis showed stroke and other peripheral vascular events to be independently associated with congestive symptoms and advanced age, as well as with atrial fibrillation (in 45 [88%] of 51 patients), at the initial evaluation. The cumulative incidence of these events among patients with atrial fibrillation was significantly higher in non-anticoagulated patients as compared with patients receiving warfarin (31% vs. 18%; p < 0.05).

CONCLUSIONS: Stroke and peripheral embolizations showed a 6% prevalence rate and an incidence of 0.8%/year in a large, unselected HCM group. These profound complications of HCM, which may lead to disability and death, were substantially more common in the elderly, occurred almost exclusively in patients with paroxysmal or chronic atrial fibrillation and appeared to be reduced in frequency by anticoagulation.

Abbreviations and Acronyms
  AF
  atrial fibrillation
  CNS
  central nervous system
  HCM
  hypertrophic cardiomyopathy
  LV
  left ventricular
  NYHA
  New York Heart Association
  TIA
  transient ischemic attack




This article has been cited by other articles:


Home page
HeartHome page
P. Elliott
Relevance of platelet activation in obstructive hypertrophic cardiomyopathy
Heart, June 1, 2008; 94(6): 688 - 689.
[Full Text] [PDF]


Home page
HeartHome page
P P Dimitrow, A Undas, M Bober, W Tracz, and J S Dubiel
Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation
Heart, June 1, 2008; 94(6): e21 - e21.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. J. Maron, P. Spirito, W.-K. Shen, T. S. Haas, F. Formisano, M. S. Link, A. E. Epstein, A. K. Almquist, J. P. Daubert, T. Lawrenz, et al.
Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
JAMA, July 25, 2007; 298(4): 405 - 412.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Kubo, J. R. Gimeno, A. Bahl, U. Steffensen, M. Steffensen, E. Osman, R. Thaman, J. Mogensen, P. M. Elliott, Y. Doi, et al.
Prevalence, Clinical Significance, and Genetic Basis of Hypertrophic Cardiomyopathy With Restrictive Phenotype
J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2419 - 2426.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Olivotto, M. S. Maron, A. S. Adabag, S. A. Casey, D. Vargiu, M. S. Link, J. E. Udelson, F. Cecchi, and B. J. Maron
Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 480 - 487.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Woo, W. G. Williams, R. Choi, E. D. Wigle, E. Rozenblyum, K. Fedwick, S. Siu, A. Ralph-Edwards, and H. Rakowski
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
Circulation, April 26, 2005; 111(16): 2033 - 2041.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Autore, P. Bernabo, C. S. Barilla, P. Bruzzi, and P. Spirito
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1076 - 1080.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
X. Liu, F. Ouyang, H. Mavrakis, C. Ma, J. Dong, S. Ernst, D. Bänsch, M. Antz, and K.-H. Kuck
Complete pulmonary vein isolation guided by three-dimensional electroanatomical mapping for the treatment of paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
Europace, January 1, 2005; 7(5): 421 - 427.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sorajja, S. R. Ommen, R. A. Nishimura, B. J. Gersh, P. B. Berger, and A. J. Tajik
Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
Circulation, November 11, 2003; 108(19): 2342 - 2348.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Risk Factors for Stroke in Patients with Hypertrophic Cardiomyopathy
Journal Watch Cardiology, April 5, 2002; 2002(405): 3 - 3.
[Full Text]


Home page
JAMAHome page
B. J. Maron
Hypertrophic Cardiomyopathy: A Systematic Review
JAMA, March 13, 2002; 287(10): 1308 - 1320.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.